Chromocell Issues Letter to Stockholders from Chief Executive Officer
FREEHOLD, N.J., April 09, 2024 -- Chromocell Therapeutics Corporation , , a pioneer in the development of non-opioid pain treatment therapeutics, today announced that its Chief Executive Officer,...